Revere Partners Returns to Yankee Dental Congress

Revere Partners, the institutional venture capital fund focused on investing at the intersection of health and oral health technology, announced today its return to the Yankee Dental Congress with its fifth consecutive “Future of Dentistry Pavilion,” highlighting emerging technologies that are shaping the evolution of dental care and medical-dental integration.

Located at Booth #2034, the 2026 Revere Innovation Pavilion will center on the theme “Liquid Gold,” spotlighting saliva as a critical diagnostic and biological driver of overall health and regenerative technologies. The pavilion will feature a curated group of early- and growth-stage companies approaching the saliva opportunity from diverse clinical, scientific, workflow, and business perspectives.

“It’s an honor to collaborate once again with the Yankee Dental Congress, as we share a strong mutual interest in accelerating the adoption of dental technology,” said Dr. Jeremy Krell, founder of Revere Partners.

The 2026 Future of Dentistry Pavilion will feature companies utilizing saliva to advance continuous health monitoring, oral cancer diagnostics, regenerative therapies, and implant stabilization technologies, reinforcing Revere Partners’ mission to support innovations that improve patient outcomes and provider experiences. The dental innovators will include:

• HysensBio: Develops regenerative technologies for dentin and periodontal tissues to support biologically driven healing.
• Lura Health: Develops saliva-based diagnostics and continuous monitoring technologies designed to identify disease risk earlier and enable proactive, personalized care.
• OrisDx: Advances diagnostic solutions for early detection of oral cancer using biomarker-driven science.
• RevBio: Develops Tetranite®, a synthetic bone adhesive designed to stabilize dental implants and craniofacial bone structures.

Over the past five years, Revere Partners’ presence at the Yankee Dental Congress has provided exposure to dozens of innovative startups, connecting founders with clinicians, industry leaders, and strategic partners seeking next-generation solutions in oral and systemic health. “Our goal has always been to provide meaningful exposure to companies driving patient-centered care, solving critical provider care gaps, and propelling medical-dental integration and whole-person care,” added Krell.

About Revere Partners

Revere Partners is the first institutional venture capital fund focused on oral and systemic health, identifying groundbreaking opportunities for investors and providing capital for cutting-edge innovations. Revere Partners aligns startups with strategic capital alongside unrivaled industry resources and growth opportunities. Founded by Dr. Jeremy Krell, Revere Partners fosters strategic partnerships that enhance care delivery while maximizing value for investors.

Learn more at www.reverepartnersvc.com or on LinkedIn.